ewtx: the cashflow

MyFinsight

For the quarter ending 2025-09-30.

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Cash Flow	2025-09-30	2025-06-30
Net cash provided by financing activities	192,113	190,454
Net change in cash and cash equivalents	4,337	1,738
Cash and cash equivalents at beginning of period	41,666	-
Cash and cash equivalents at end of period	46,003	-

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

For the quarter ending 2025-09-30.

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Cash Flow	2025-09-30	2025-06-30
Net cash provided by financing activities	192,113	190,454
Net change in cash and cash equivalents	4,337	1,738
Cash and cash equivalents at beginning of period	41,666	-
Cash and cash equivalents at end of period	46,003	-

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Edgewise Therapeutics, Inc. (EWTX)